KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash & Current Investments (2016 - 2025)

Pfizer (PFE) has disclosed Cash & Current Investments for 17 consecutive years, with $13.6 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 33.6% to $13.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.6 billion through Dec 2025, down 33.6% year-over-year, with the annual reading at $13.6 billion for FY2025, 33.6% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $13.6 billion at Pfizer, down from $15.0 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $44.8 billion in Q3 2023, with the low at $7.1 billion in Q2 2024.
  • Average Cash & Current Investments over 5 years is $22.1 billion, with a median of $20.2 billion recorded in 2023.
  • The sharpest move saw Cash & Current Investments surged 182.85% in 2021, then plummeted 84.15% in 2024.
  • Over 5 years, Cash & Current Investments stood at $31.1 billion in 2021, then dropped by 26.83% to $22.7 billion in 2022, then crashed by 44.18% to $12.7 billion in 2023, then skyrocketed by 61.36% to $20.5 billion in 2024, then crashed by 33.6% to $13.6 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $13.6 billion, $15.0 billion, and $13.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.